France In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 France In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. France In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of France In-Vitro Diagnostics Industry

France is a developed region with a well-structured healthcare system. As a result, many players in the in-vitro diagnostics market are present in the country. Thus, the in-vitro diagnostic market in France is fairly fragmented, with the presence of local players competing in the market. Some of the players in the market include Abbott Laboratories, F. Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fischer Scientific Inc., BioMerieux and Becton, Dickinson and Company.

France In-Vitro Diagnostics Market Leaders

  1. Thermo Fischer Scientific Inc

  2. QIAGEN N.V.

  3. Siemens Healthcare GmbH

  4. F. Hoffmann-La Roche AG

  5. Abbott Laboratories

*Disclaimer: Major Players sorted in no particular order

France In-Vitro Diagnostics Market Concentration

In Vitro Diagnostics Market in France Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)